Cargando…
Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial)
INTRODUCTION: The current evidence on the efficacy of antibiotic-loaded bone cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insufficient. In several European countries, the use of ALBC is routine practice unlike in the USA where ALBC...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845702/ https://www.ncbi.nlm.nih.gov/pubmed/33509845 http://dx.doi.org/10.1136/bmjopen-2020-041096 |
_version_ | 1783644604383363072 |
---|---|
author | Leta, Tesfaye H Gjertsen, Jan-Erik Dale, Håvard Hallan, Geir Lygre, Stein Håkon Låstad Fenstad, Anne Marie Dyrhovden, Gro Sævik Westberg, Marianne Wik, Tina Stromdal Jakobsen, Rune Bruhn Aamodt, Arild Röhrl, Stephan Maximillian Gøthesen, Øystein Johannes Lindalen, Einar Heir, Stig Ludvigsen, Jarle Bruun, Trond Hansen, Ann Kristin Aune, Knut Erik Moen Warholm, Marianne Skjetne, John Petter Badawy, Mona Høvding, Pål Husby, Otto Schnell Karlsen, Øystein Espeland Furnes, Ove |
author_facet | Leta, Tesfaye H Gjertsen, Jan-Erik Dale, Håvard Hallan, Geir Lygre, Stein Håkon Låstad Fenstad, Anne Marie Dyrhovden, Gro Sævik Westberg, Marianne Wik, Tina Stromdal Jakobsen, Rune Bruhn Aamodt, Arild Röhrl, Stephan Maximillian Gøthesen, Øystein Johannes Lindalen, Einar Heir, Stig Ludvigsen, Jarle Bruun, Trond Hansen, Ann Kristin Aune, Knut Erik Moen Warholm, Marianne Skjetne, John Petter Badawy, Mona Høvding, Pål Husby, Otto Schnell Karlsen, Øystein Espeland Furnes, Ove |
author_sort | Leta, Tesfaye H |
collection | PubMed |
description | INTRODUCTION: The current evidence on the efficacy of antibiotic-loaded bone cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insufficient. In several European countries, the use of ALBC is routine practice unlike in the USA where ALBC use is not approved in low-risk patients. Therefore, we designed a double-blinded pragmatic multicentre register-based randomised controlled non-inferiority trial to investigate the effects of ALBC compared with plain bone cement in primary total knee arthroplasty (TKA). METHODS AND ANALYSIS: A minimum of 9,172 patients undergoing full-cemented primary TKA will be recruited and equally randomised into the ALBC group and the plain bone cement group. This trial will be conducted in Norwegian hospitals that routinely perform cemented primary TKA. The primary outcome will be risk of revision surgery due to PJI at 1-year of follow-up. Secondary outcomes will be: risk of revision due to any reason including aseptic loosening at 1, 6, 10 and 20 years of follow-up; patient-related outcome measures like function, pain, satisfaction and health-related quality of life at 1, 6 and 10 years of follow-up; risk of changes in the microbial pattern and resistance profiles of organisms cultured in subsequent revisions at 1, 6, 10 and 20 years of follow-up; cost-effectiveness of routine ALBC versus plain bone cement use in primary TKA. We will use 1:1 randomisation with random permuted blocks and stratify by participating hospitals to randomise patients to receive ALBC or plain bone cement. Inclusion, randomisation and follow-up will be through the Norwegian Arthroplasty Register. ETHICS AND DISSEMINATION: The trial was approved by the Western Norway Regional Committees on Medical and Health Research Ethics (reference number: 2019/751/REK vest) on 21 June 2019. The findings of this trial will be disseminated through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: NCT04135170. |
format | Online Article Text |
id | pubmed-7845702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-78457022021-02-04 Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) Leta, Tesfaye H Gjertsen, Jan-Erik Dale, Håvard Hallan, Geir Lygre, Stein Håkon Låstad Fenstad, Anne Marie Dyrhovden, Gro Sævik Westberg, Marianne Wik, Tina Stromdal Jakobsen, Rune Bruhn Aamodt, Arild Röhrl, Stephan Maximillian Gøthesen, Øystein Johannes Lindalen, Einar Heir, Stig Ludvigsen, Jarle Bruun, Trond Hansen, Ann Kristin Aune, Knut Erik Moen Warholm, Marianne Skjetne, John Petter Badawy, Mona Høvding, Pål Husby, Otto Schnell Karlsen, Øystein Espeland Furnes, Ove BMJ Open Surgery INTRODUCTION: The current evidence on the efficacy of antibiotic-loaded bone cement (ALBC) in reducing the risk of periprosthetic joint infections (PJI) after primary joint reconstruction is insufficient. In several European countries, the use of ALBC is routine practice unlike in the USA where ALBC use is not approved in low-risk patients. Therefore, we designed a double-blinded pragmatic multicentre register-based randomised controlled non-inferiority trial to investigate the effects of ALBC compared with plain bone cement in primary total knee arthroplasty (TKA). METHODS AND ANALYSIS: A minimum of 9,172 patients undergoing full-cemented primary TKA will be recruited and equally randomised into the ALBC group and the plain bone cement group. This trial will be conducted in Norwegian hospitals that routinely perform cemented primary TKA. The primary outcome will be risk of revision surgery due to PJI at 1-year of follow-up. Secondary outcomes will be: risk of revision due to any reason including aseptic loosening at 1, 6, 10 and 20 years of follow-up; patient-related outcome measures like function, pain, satisfaction and health-related quality of life at 1, 6 and 10 years of follow-up; risk of changes in the microbial pattern and resistance profiles of organisms cultured in subsequent revisions at 1, 6, 10 and 20 years of follow-up; cost-effectiveness of routine ALBC versus plain bone cement use in primary TKA. We will use 1:1 randomisation with random permuted blocks and stratify by participating hospitals to randomise patients to receive ALBC or plain bone cement. Inclusion, randomisation and follow-up will be through the Norwegian Arthroplasty Register. ETHICS AND DISSEMINATION: The trial was approved by the Western Norway Regional Committees on Medical and Health Research Ethics (reference number: 2019/751/REK vest) on 21 June 2019. The findings of this trial will be disseminated through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: NCT04135170. BMJ Publishing Group 2021-01-28 /pmc/articles/PMC7845702/ /pubmed/33509845 http://dx.doi.org/10.1136/bmjopen-2020-041096 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Surgery Leta, Tesfaye H Gjertsen, Jan-Erik Dale, Håvard Hallan, Geir Lygre, Stein Håkon Låstad Fenstad, Anne Marie Dyrhovden, Gro Sævik Westberg, Marianne Wik, Tina Stromdal Jakobsen, Rune Bruhn Aamodt, Arild Röhrl, Stephan Maximillian Gøthesen, Øystein Johannes Lindalen, Einar Heir, Stig Ludvigsen, Jarle Bruun, Trond Hansen, Ann Kristin Aune, Knut Erik Moen Warholm, Marianne Skjetne, John Petter Badawy, Mona Høvding, Pål Husby, Otto Schnell Karlsen, Øystein Espeland Furnes, Ove Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title | Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title_full | Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title_fullStr | Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title_full_unstemmed | Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title_short | Antibiotic-Loaded Bone Cement in Prevention of Periprosthetic Joint Infections in Primary Total Knee Arthroplasty: A Register-based Multicentre Randomised Controlled Non-inferiority Trial (ALBA trial) |
title_sort | antibiotic-loaded bone cement in prevention of periprosthetic joint infections in primary total knee arthroplasty: a register-based multicentre randomised controlled non-inferiority trial (alba trial) |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845702/ https://www.ncbi.nlm.nih.gov/pubmed/33509845 http://dx.doi.org/10.1136/bmjopen-2020-041096 |
work_keys_str_mv | AT letatesfayeh antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT gjertsenjanerik antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT dalehavard antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT hallangeir antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT lygresteinhakonlastad antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT fenstadannemarie antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT dyrhovdengrosævik antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT westbergmarianne antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT wiktinastromdal antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT jakobsenrunebruhn antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT aamodtarild antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT rohrlstephanmaximillian antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT gøthesenøysteinjohannes antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT lindaleneinar antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT heirstig antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT ludvigsenjarle antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT bruuntrond antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT hansenannkristin antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT auneknuterikmoen antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT warholmmarianne antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT skjetnejohnpetter antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT badawymona antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT høvdingpal antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT husbyottoschnell antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT karlsenøysteinespeland antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial AT furnesove antibioticloadedbonecementinpreventionofperiprostheticjointinfectionsinprimarytotalkneearthroplastyaregisterbasedmulticentrerandomisedcontrollednoninferioritytrialalbatrial |